[First results apropos of 23 observations on the possibilities of fibrinolytic treatment during retinal venous thrombosis].
D000328:Adult; D000368:Aged; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D012160:Retina / Q000098:blood supply; D012169:Retinal Vein; D013300:Streptokinase / Q000627:therapeutic use*; D013924:Thrombophlebitis / Q000188:drug therapy*; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*; D014786:Vision Disorders / Q000209:etiology; D014792:Visual Acuity
D005343:Fibrinolytic Agents; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator
Nos premiers resultats à propos de 23 observations sur les possibilités du traitment fibrinolytique au cours des thromboses veineuses rétiniennes